172 related articles for article (PubMed ID: 21742680)
1. Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking.
Lachance DH; Yang P; Johnson DR; Decker PA; Kollmeyer TM; McCoy LS; Rice T; Xiao Y; Ali-Osman F; Wang F; Stoddard SM; Sprau DJ; Kosel ML; Wiencke JK; Wiemels JL; Patoka JS; Davis F; McCarthy B; Rynearson AL; Worra JB; Fridley BL; O'Neill BP; Buckner JC; Il'yasova D; Jenkins RB; Wrensch MR
Am J Epidemiol; 2011 Sep; 174(5):574-81. PubMed ID: 21742680
[TBL] [Abstract][Full Text] [Related]
2. Interaction between 5 genetic variants and allergy in glioma risk.
Schoemaker MJ; Robertson L; Wigertz A; Jones ME; Hosking FJ; Feychting M; Lönn S; McKinney PA; Hepworth SJ; Muir KR; Auvinen A; Salminen T; Kiuru A; Johansen C; Houlston RS; Swerdlow AJ
Am J Epidemiol; 2010 Jun; 171(11):1165-73. PubMed ID: 20462933
[TBL] [Abstract][Full Text] [Related]
3. Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26.
Alpen K; Vajdic CM; MacInnis RJ; Milne RL; Koh ES; Hovey E; Harrup R; Bruinsma F; Nguyen TL; Li S; Joseph D; Benke G; Dugué PA; Southey MC; Giles GG; Rosenthal M; Drummond KJ; Nowak AK; Hopper JL; Kapuscinski M; Makalic E
Neuro Oncol; 2023 Jul; 25(7):1355-1365. PubMed ID: 36541697
[TBL] [Abstract][Full Text] [Related]
4. Distinct germ line polymorphisms underlie glioma morphologic heterogeneity.
Jenkins RB; Wrensch MR; Johnson D; Fridley BL; Decker PA; Xiao Y; Kollmeyer TM; Rynearson AL; Fink S; Rice T; McCoy LS; Halder C; Kosel ML; Giannini C; Tihan T; O'Neill BP; Lachance DH; Yang P; Wiemels J; Wiencke JK
Cancer Genet; 2011 Jan; 204(1):13-8. PubMed ID: 21356187
[TBL] [Abstract][Full Text] [Related]
5. Known glioma risk loci are associated with glioma with a family history of brain tumours -- a case-control gene association study.
Melin B; Dahlin AM; Andersson U; Wang Z; Henriksson R; Hallmans G; Bondy ML; Johansen C; Feychting M; Ahlbom A; Kitahara CM; Wang SS; Ruder AM; Carreón T; Butler MA; Inskip PD; Purdue M; Hsing AW; Mechanic L; Gillanders E; Yeager M; Linet M; Chanock SJ; Hartge P; Rajaraman P
Int J Cancer; 2013 May; 132(10):2464-8. PubMed ID: 23115063
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide association study identifies five susceptibility loci for glioma.
Shete S; Hosking FJ; Robertson LB; Dobbins SE; Sanson M; Malmer B; Simon M; Marie Y; Boisselier B; Delattre JY; Hoang-Xuan K; El Hallani S; Idbaih A; Zelenika D; Andersson U; Henriksson R; Bergenheim AT; Feychting M; Lönn S; Ahlbom A; Schramm J; Linnebank M; Hemminki K; Kumar R; Hepworth SJ; Price A; Armstrong G; Liu Y; Gu X; Yu R; Lau C; Schoemaker M; Muir K; Swerdlow A; Lathrop M; Bondy M; Houlston RS
Nat Genet; 2009 Aug; 41(8):899-904. PubMed ID: 19578367
[TBL] [Abstract][Full Text] [Related]
7. Fine mapping analysis of a region of 20q13.33 identified five independent susceptibility loci for glioma in a Chinese Han population.
Song X; Zhou K; Zhao Y; Huai C; Zhao Y; Yu H; Chen Y; Chen G; Chen H; Fan W; Mao Y; Lu D
Carcinogenesis; 2012 May; 33(5):1065-71. PubMed ID: 22387365
[TBL] [Abstract][Full Text] [Related]
8. Association of sequence variants on chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15.33) with glioma susceptibility in a Chinese population.
Chen H; Chen Y; Zhao Y; Fan W; Zhou K; Liu Y; Zhou L; Mao Y; Wei Q; Xu J; Lu D
Am J Epidemiol; 2011 Apr; 173(8):915-22. PubMed ID: 21350045
[TBL] [Abstract][Full Text] [Related]
9. Genetic risk profiles identify different molecular etiologies for glioma.
Simon M; Hosking FJ; Marie Y; Gousias K; Boisselier B; Carpentier C; Schramm J; Mokhtari K; Hoang-Xuan K; Idbaih A; Delattre JY; Lathrop M; Robertson LB; Houlston RS; Sanson M
Clin Cancer Res; 2010 Nov; 16(21):5252-9. PubMed ID: 20847058
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide association study of glioma and meta-analysis.
Rajaraman P; Melin BS; Wang Z; McKean-Cowdin R; Michaud DS; Wang SS; Bondy M; Houlston R; Jenkins RB; Wrensch M; Yeager M; Ahlbom A; Albanes D; Andersson U; Freeman LE; Buring JE; Butler MA; Braganza M; Carreon T; Feychting M; Fleming SJ; Gapstur SM; Gaziano JM; Giles GG; Hallmans G; Henriksson R; Hoffman-Bolton J; Inskip PD; Johansen C; Kitahara CM; Lathrop M; Liu C; Le Marchand L; Linet MS; Lonn S; Peters U; Purdue MP; Rothman N; Ruder AM; Sanson M; Sesso HD; Severi G; Shu XO; Simon M; Stampfer M; Stevens VL; Visvanathan K; White E; Wolk A; Zeleniuch-Jacquotte A; Zheng W; Decker P; Enciso-Mora V; Fridley B; Gao YT; Kosel M; Lachance DH; Lau C; Rice T; Swerdlow A; Wiemels JL; Wiencke JK; Shete S; Xiang YB; Xiao Y; Hoover RN; Fraumeni JF; Chatterjee N; Hartge P; Chanock SJ
Hum Genet; 2012 Dec; 131(12):1877-88. PubMed ID: 22886559
[TBL] [Abstract][Full Text] [Related]
11. Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma.
Ghasimi S; Wibom C; Dahlin AM; Brännström T; Golovleva I; Andersson U; Melin B
J Neurooncol; 2016 May; 127(3):483-92. PubMed ID: 26839018
[TBL] [Abstract][Full Text] [Related]
12. Investigation of established genetic risk variants for glioma in prediagnostic samples from a population-based nested case-control study.
Wibom C; Späth F; Dahlin AM; Langseth H; Hovig E; Rajaraman P; Johannesen TB; Andersson U; Melin B
Cancer Epidemiol Biomarkers Prev; 2015 May; 24(5):810-6. PubMed ID: 25713050
[TBL] [Abstract][Full Text] [Related]
13. Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients.
Viana-Pereira M; Moreno DA; Linhares P; Amorim J; Nabiço R; Costa S; Vaz R; Reis RM
Mol Biol Rep; 2020 Feb; 47(2):877-886. PubMed ID: 31721021
[TBL] [Abstract][Full Text] [Related]
14. Genetic causes of glioma: new leads in the labyrinth.
Melin B
Curr Opin Oncol; 2011 Nov; 23(6):643-7. PubMed ID: 21825990
[TBL] [Abstract][Full Text] [Related]
15. Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologies.
Di Stefano AL; Enciso-Mora V; Marie Y; Desestret V; Labussière M; Boisselier B; Mokhtari K; Idbaih A; Hoang-Xuan K; Delattre JY; Houlston RS; Sanson M
Neuro Oncol; 2013 May; 15(5):542-7. PubMed ID: 23161787
[TBL] [Abstract][Full Text] [Related]
16. Joint effects between five identified risk variants, allergy, and autoimmune conditions on glioma risk.
Safaeian M; Rajaraman P; Hartge P; Yeager M; Linet M; Butler MA; Ruder AM; Purdue MP; Hsing A; Beane-Freeman L; Hoppin JA; Albanes D; Weinstein SJ; Inskip PD; Brenner A; Rothman N; Chatterjee N; Gillanders EM; Chanock SJ; Wang SS
Cancer Causes Control; 2013 Oct; 24(10):1885-91. PubMed ID: 23903690
[TBL] [Abstract][Full Text] [Related]
17. Allergy may confer better survival on patients with gliomas.
Lehrer S; Rheinstein PH; Rosenzweig KE
Clin Neurol Neurosurg; 2019 Feb; 177():63-67. PubMed ID: 30611004
[TBL] [Abstract][Full Text] [Related]
18. Association analysis of RTEL1 variants with risk of adult gliomas in a Korean population.
Namgoong S; Cheong HS; Kim JH; Kim LH; Seo JY; Kang SG; Yoon SJ; Kim SH; Chang JH; Shin HD
PLoS One; 2018; 13(11):e0207660. PubMed ID: 30462709
[TBL] [Abstract][Full Text] [Related]
19. Functional analysis of the 11q23.3 glioma susceptibility locus implicates PHLDB1 and DDX6 in glioma susceptibility.
Baskin R; Woods NT; Mendoza-Fandiño G; Forsyth P; Egan KM; Monteiro AN
Sci Rep; 2015 Nov; 5():17367. PubMed ID: 26610392
[TBL] [Abstract][Full Text] [Related]
20. Relation between Established Glioma Risk Variants and DNA Methylation in the Tumor.
Dahlin AM; Wibom C; Ghasimi S; Brännström T; Andersson U; Melin B
PLoS One; 2016; 11(10):e0163067. PubMed ID: 27780202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
